Growth Metrics

Moderna (MRNA) Asset Utilization Ratio: 2019-2025

Historic Asset Utilization Ratio for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to 0.18.

  • Moderna's Asset Utilization Ratio fell 41.98% to 0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18, marking a year-over-year decrease of 41.98%. This contributed to the annual value of 0.20 for FY2024, which is 35.75% down from last year.
  • Per Moderna's latest filing, its Asset Utilization Ratio stood at 0.18 for Q3 2025, which was down 25.78% from 0.25 recorded in Q2 2025.
  • In the past 5 years, Moderna's Asset Utilization Ratio ranged from a high of 0.86 in Q1 2022 and a low of 0.18 during Q3 2025.
  • Its 3-year average for Asset Utilization Ratio is 0.33, with a median of 0.31 in 2024.
  • Per our database at Business Quant, Moderna's Asset Utilization Ratio soared by 1,173.58% in 2021 and then slumped by 51.35% in 2024.
  • Over the past 5 years, Moderna's Asset Utilization Ratio (Quarterly) stood at 0.81 in 2021, then declined by 8.41% to 0.74 in 2022, then plummeted by 51.27% to 0.36 in 2023, then plummeted by 41.43% to 0.21 in 2024, then tumbled by 41.98% to 0.18 in 2025.
  • Its last three reported values are 0.18 in Q3 2025, 0.25 for Q2 2025, and 0.23 during Q1 2025.